Average Co-Inventor Count = 11.22
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (17 from 3,923 patents)
2. Novartis Vaccines & Diagnostics, Gmbh (9 from 245 patents)
3. University of Washington (4 from 2,103 patents)
4. Chiron Corporation (4 from 656 patents)
5. Korea Research Institute of Chemical Technology (2 from 624 patents)
6. Katholieke Universiteit Leuven (2 from 346 patents)
7. Other (1 from 832,843 patents)
31 patents:
1. 12286423 - Antiviral 1,3-di-oxo-indene compounds
2. 12083092 - Antiviral 1,3-di-oxo-indene compounds
3. 11234977 - Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
4. 10975078 - Fused indazole pyridone compounds as antivirals
5. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors
6. 10301312 - Fused indazole pyridone compounds as antivirals
7. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors
8. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors
9. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors
10. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
11. 8778951 - Heteroaryl compounds and their uses
12. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
13. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors
14. 8415381 - Heteroaryl compounds and their uses
15. 8293769 - CSF-1R inhibitors, compositions, and methods of use